Turning to natural gas, Steiner said 90% to 95% of all new Waste Management trucks will run on natural gas, and the company is committed to using it wherever available. Along the same lines, Steiner noted that his company now generates more than five times the energy from methane at its landfills than the entire U.S. solar industry, which is a huge endorsement for U.S.-made and renewable energy.
Cramer said he continues to like the Waste Management story and the rally in this stock is likely still in its early stages.
Speculative Stocks, Long-Term Prospects
Continuing with his series on small, more speculative biotech companies, Cramer gave viewers a three-for-one special by recommending Vertex Pharmaceuticals (VRTX), Sarepta Therapeutics (SRPT) and NPS Pharmaceuticals (NPSP), all three of which have excellent long-term prospects.
Cramer said Vertex is 11 points off its highs, but that doesn't make the company's cystic fibrosis treatments any less valuable. He said the company's main drug, which is only approved for a small subset of the 70,000 patients suffering from the disease, is already doing well, while its next-generation treatments are in phase III and phase II testing, with results expected soon.Sarepta is working in the muscular dystrophy space and has already seen a 152% gain since Cramer first took notice of the company on Sept. 21. The company is filing for accelerated approval for its latest treatment, which not only stops degeneration but has actually helped patients improve. Cramer said the long-term prospects for Sarepta are excellent, even if accelerated approval is not granted. Finally, there's NPS, a company whose CEO appeared on "Mad Money" just two weeks ago. Cramer said NPS' treatment for short bowel syndrome is a game-changer for those currently forced to endure daily hospital stays for 12 hours at a time. Any of these orphan drug makers could hit it big, Cramer concluded, which is why at least one should be in every investor's portfolio.
Lightning RoundIn the Lightning Round, Cramer was bullish on Iconix Brands (ICON), US Airways Group (LCC) and USG Corp (USG). Cramer was bearish on JetBlue Airways (JBLU).
Executive Decision: Tom FarrellIn a second "Executive Decision" segment, Cramer spoke with Tom Farrell, chairman, president and CEO of Dominion Resources (D), a company hoping to build an import/export terminal for liquified natural gas in Maryland and have it operational by 2017. Shares of Dominion are currently up 15% since Cramer last recommended it Dec. 6 and offer a 3.8% yield. Farrell explained that Dominion already has much of the infrastructure for this project in place at its Maryland facility, including 15 billion cubic feet of natural gas storage, a super-tanker terminal and, most importantly, a pipeline that runs into the heart of the Marcellus and Utica shale regions of the country. The only missing piece, he said, is the equipment to liquify the gas, which will cost around $4 billion. Farrell also said Dominion has signed both construction contracts to build the facility and has contracts in place to sell the gas once it's completed. When asked why the company chose to sign contracts before getting full regulatory approval, Farrell said he has full confidence the remaining permits will be granted in the coming months. Asked whether America will lose its competitive advantage by exporting such a cheap and plentiful resource, Farrell said that in order for natural gas to truly succeed it will need a robust market, which includes some exports. He said it's highly unlikely that Dominion, or any other company, will have unfettered export abilities. But by having exports as part of the mix, drillers will always have a reason to keep drilling. Cramer continued his support for Dominion and its bold initiatives.
No Huddle OffenseIn his "No Huddle Offense" segment, Cramer said he's still not ready to sound the "all clear" on Apple, but the bottom may be beginning to form. Cramer explained that stocks bottom much like they top out, with analyst after analyst changing their minds on the company and eventually creating a self-fulfilling prophecy. That's why today's downgrade by Goldman Sachs (GS) matters, said Cramer -- not because the company had anything new to say, but it's just one more analyst that hates Apple. When there's no one left to like it, said Cramer, only then will the bottom be at hand. To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.